Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-02-02

AUTHORS

Eun-Ju Lee, Cristian Mircean, Ilya Shmulevich, Huamin Wang, Jinsong Liu, Antti Niemistö, John J Kavanagh, Je-Ho Lee, Wei Zhang

ABSTRACT

BACKGROUND: Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in ovarian malignant tissues and in the serum and cystic fluid of ovarian cancer patients, suggesting an important role of IGFBP2 in the biology of ovarian cancer. The purpose of this study was to assess the role of increased IGFBP2 in ovarian cancer cells. RESULTS: Using western blotting and tissue microarray analyses, we showed that IGFBP2 was frequently overexpressed in ovarian carcinomas compared with normal ovarian tissues. Furthermore, IGFBP2 was significantly overexpressed in invasive serous ovarian carcinomas compared with borderline serous ovarian tumors. To test whether increased IGFBP2 contributes to the highly invasive nature of ovarian cancer cells, we generated IGFBP2-overexpressing cells from an SKOV3 ovarian cancer cell line, which has a very low level of endogenous IGFBP2. A Matrigel invasion assay showed that these IGFBP2-overexpressing cells were more invasive than the control cells. We then designed small interference RNA (siRNA) molecules that attenuated IGFBP2 expression in PA-1 ovarian cancer cells, which have a high level of endogenous IGFBP2. The Matrigel invasion assay showed that the attenuation of IGFBP2 expression indeed decreased the invasiveness of PA-1 cells. CONCLUSIONS: We therefore showed that IGFBP2 enhances the invasion capacity of ovarian cancer cells. Blockage of IGFBP2 may thus constitute a viable strategy for targeted cancer therapy. More... »

PAGES

7-7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1476-4598-4-7

DOI

http://dx.doi.org/10.1186/1476-4598-4-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029582210

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15686601


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin-Like Growth Factor Binding Protein 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Small Interfering", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135\u2013710, Korea", 
          "id": "http://www.grid.ac/institutes/grid.414964.a", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
            "Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
            "Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135\u2013710, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Eun-Ju", 
        "id": "sg:person.014144227613.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014144227613.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Signal Processing, Tampere University of Technology, Tampere, Finland", 
          "id": "http://www.grid.ac/institutes/grid.502801.e", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
            "Institute of Signal Processing, Tampere University of Technology, Tampere, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mircean", 
        "givenName": "Cristian", 
        "id": "sg:person.01243262074.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243262074.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shmulevich", 
        "givenName": "Ilya", 
        "id": "sg:person.01354314446.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354314446.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Huamin", 
        "id": "sg:person.013334470427.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334470427.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Jinsong", 
        "id": "sg:person.010300733047.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010300733047.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Signal Processing, Tampere University of Technology, Tampere, Finland", 
          "id": "http://www.grid.ac/institutes/grid.502801.e", 
          "name": [
            "Institute of Signal Processing, Tampere University of Technology, Tampere, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niemist\u00f6", 
        "givenName": "Antti", 
        "id": "sg:person.01117750401.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117750401.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kavanagh", 
        "givenName": "John J", 
        "id": "sg:person.01364414205.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364414205.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135\u2013710, Korea", 
          "id": "http://www.grid.ac/institutes/grid.414964.a", 
          "name": [
            "Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135\u2013710, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Je-Ho", 
        "id": "sg:person.01266571735.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266571735.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Wei", 
        "id": "sg:person.016617025407.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016617025407.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1016/j.jsgi.2003.07.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054739612", 
          "https://doi.org/10.1016/j.jsgi.2003.07.004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1996.206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004364659", 
          "https://doi.org/10.1038/bjc.1996.206"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00428-003-0786-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075266389", 
          "https://doi.org/10.1007/s00428-003-0786-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.3800120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038132444", 
          "https://doi.org/10.1038/modpathol.3800120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035416773", 
          "https://doi.org/10.1038/bjc.1990.163"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-02-02", 
    "datePublishedReg": "2005-02-02", 
    "description": "BACKGROUND: Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in ovarian malignant tissues and in the serum and cystic fluid of ovarian cancer patients, suggesting an important role of IGFBP2 in the biology of ovarian cancer. The purpose of this study was to assess the role of increased IGFBP2 in ovarian cancer cells.\nRESULTS: Using western blotting and tissue microarray analyses, we showed that IGFBP2 was frequently overexpressed in ovarian carcinomas compared with normal ovarian tissues. Furthermore, IGFBP2 was significantly overexpressed in invasive serous ovarian carcinomas compared with borderline serous ovarian tumors. To test whether increased IGFBP2 contributes to the highly invasive nature of ovarian cancer cells, we generated IGFBP2-overexpressing cells from an SKOV3 ovarian cancer cell line, which has a very low level of endogenous IGFBP2. A Matrigel invasion assay showed that these IGFBP2-overexpressing cells were more invasive than the control cells. We then designed small interference RNA (siRNA) molecules that attenuated IGFBP2 expression in PA-1 ovarian cancer cells, which have a high level of endogenous IGFBP2. The Matrigel invasion assay showed that the attenuation of IGFBP2 expression indeed decreased the invasiveness of PA-1 cells.\nCONCLUSIONS: We therefore showed that IGFBP2 enhances the invasion capacity of ovarian cancer cells. Blockage of IGFBP2 may thus constitute a viable strategy for targeted cancer therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1476-4598-4-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031030", 
        "issn": [
          "1476-4598"
        ], 
        "name": "Molecular Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "ovarian cancer cells", 
      "insulin-like growth factor", 
      "IGFBP2 expression", 
      "cancer cells", 
      "ovarian carcinoma", 
      "Matrigel invasion", 
      "invasive serous ovarian carcinomas", 
      "borderline serous ovarian tumors", 
      "ovarian cancer cell invasion", 
      "growth factor", 
      "ovarian malignant tissues", 
      "ovarian cancer cell lines", 
      "ovarian cancer patients", 
      "serous ovarian tumors", 
      "normal ovarian tissues", 
      "SKOV3 ovarian cancer cell line", 
      "serous ovarian carcinoma", 
      "PA-1 ovarian cancer cells", 
      "tissue microarray analysis", 
      "protein 2", 
      "cancer cell invasion", 
      "cancer cell lines", 
      "cancer patients", 
      "ovarian tumors", 
      "small interference RNA (siRNA) molecules", 
      "cystic fluid", 
      "ovarian cancer", 
      "PA-1 cells", 
      "ovarian tissue", 
      "invasion capacity", 
      "invasive nature", 
      "IGFBP2", 
      "malignant tissues", 
      "Western blotting", 
      "cell invasion", 
      "cancer therapy", 
      "control cells", 
      "carcinoma", 
      "cell lines", 
      "microarray analysis", 
      "invasion", 
      "cells", 
      "tissue", 
      "low levels", 
      "high levels", 
      "patients", 
      "therapy", 
      "tumors", 
      "expression", 
      "cancer", 
      "important role", 
      "viable strategy", 
      "blotting", 
      "factors", 
      "levels", 
      "invasiveness", 
      "role", 
      "blockage", 
      "study", 
      "RNA molecules", 
      "fluid", 
      "attenuation", 
      "purpose", 
      "strategies", 
      "biology", 
      "lines", 
      "analysis", 
      "capacity", 
      "molecules", 
      "nature", 
      "endogenous IGFBP2", 
      "interference RNA (siRNA) molecules", 
      "Blockage of IGFBP2"
    ], 
    "name": "Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion", 
    "pagination": "7-7", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029582210"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1476-4598-4-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15686601"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1476-4598-4-7", 
      "https://app.dimensions.ai/details/publication/pub.1029582210"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_410.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1476-4598-4-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1476-4598-4-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1476-4598-4-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1476-4598-4-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1476-4598-4-7'


 

This table displays all metadata directly associated to this object as RDF triples.

253 TRIPLES      22 PREDICATES      112 URIs      98 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1476-4598-4-7 schema:about N16ea8b02400646c9966e79c5a5e0c295
2 N1f22096a0e7c4062a400cbb042c1f0c0
3 N211e4ec402e54e6b89326a57ad46b26c
4 N46d39e96b9ab4792bd7a580ac5681538
5 N8a3c118b154643bd8c5d3602e545bb1f
6 N99cdcb5d38004771b850352aff596872
7 Nb9b3998dd2ae41a4a19401a2cf6e4cae
8 anzsrc-for:11
9 anzsrc-for:1103
10 anzsrc-for:1112
11 schema:author N6d72cd00110343fb8a3a33dbb5410c84
12 schema:citation sg:pub.10.1007/s00428-003-0786-2
13 sg:pub.10.1016/j.jsgi.2003.07.004
14 sg:pub.10.1038/bjc.1990.163
15 sg:pub.10.1038/bjc.1996.206
16 sg:pub.10.1038/modpathol.3800120
17 schema:datePublished 2005-02-02
18 schema:datePublishedReg 2005-02-02
19 schema:description BACKGROUND: Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in ovarian malignant tissues and in the serum and cystic fluid of ovarian cancer patients, suggesting an important role of IGFBP2 in the biology of ovarian cancer. The purpose of this study was to assess the role of increased IGFBP2 in ovarian cancer cells. RESULTS: Using western blotting and tissue microarray analyses, we showed that IGFBP2 was frequently overexpressed in ovarian carcinomas compared with normal ovarian tissues. Furthermore, IGFBP2 was significantly overexpressed in invasive serous ovarian carcinomas compared with borderline serous ovarian tumors. To test whether increased IGFBP2 contributes to the highly invasive nature of ovarian cancer cells, we generated IGFBP2-overexpressing cells from an SKOV3 ovarian cancer cell line, which has a very low level of endogenous IGFBP2. A Matrigel invasion assay showed that these IGFBP2-overexpressing cells were more invasive than the control cells. We then designed small interference RNA (siRNA) molecules that attenuated IGFBP2 expression in PA-1 ovarian cancer cells, which have a high level of endogenous IGFBP2. The Matrigel invasion assay showed that the attenuation of IGFBP2 expression indeed decreased the invasiveness of PA-1 cells. CONCLUSIONS: We therefore showed that IGFBP2 enhances the invasion capacity of ovarian cancer cells. Blockage of IGFBP2 may thus constitute a viable strategy for targeted cancer therapy.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree true
23 schema:isPartOf N9b57ab8056ee4181820ac9e56800f9b6
24 Nf1255d1c23024f9e856ce717cdf899ac
25 sg:journal.1031030
26 schema:keywords Blockage of IGFBP2
27 IGFBP2
28 IGFBP2 expression
29 Matrigel invasion
30 PA-1 cells
31 PA-1 ovarian cancer cells
32 RNA molecules
33 SKOV3 ovarian cancer cell line
34 Western blotting
35 analysis
36 attenuation
37 biology
38 blockage
39 blotting
40 borderline serous ovarian tumors
41 cancer
42 cancer cell invasion
43 cancer cell lines
44 cancer cells
45 cancer patients
46 cancer therapy
47 capacity
48 carcinoma
49 cell invasion
50 cell lines
51 cells
52 control cells
53 cystic fluid
54 endogenous IGFBP2
55 expression
56 factors
57 fluid
58 growth factor
59 high levels
60 important role
61 insulin-like growth factor
62 interference RNA (siRNA) molecules
63 invasion
64 invasion capacity
65 invasive nature
66 invasive serous ovarian carcinomas
67 invasiveness
68 levels
69 lines
70 low levels
71 malignant tissues
72 microarray analysis
73 molecules
74 nature
75 normal ovarian tissues
76 ovarian cancer
77 ovarian cancer cell invasion
78 ovarian cancer cell lines
79 ovarian cancer cells
80 ovarian cancer patients
81 ovarian carcinoma
82 ovarian malignant tissues
83 ovarian tissue
84 ovarian tumors
85 patients
86 protein 2
87 purpose
88 role
89 serous ovarian carcinoma
90 serous ovarian tumors
91 small interference RNA (siRNA) molecules
92 strategies
93 study
94 therapy
95 tissue
96 tissue microarray analysis
97 tumors
98 viable strategy
99 schema:name Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion
100 schema:pagination 7-7
101 schema:productId N5acc90b72621475c97e2f112e096d5cc
102 N649c0a772ee941e6bc0ea1beaed00516
103 Nf820e34dc72e40d3919f7c75138658e2
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029582210
105 https://doi.org/10.1186/1476-4598-4-7
106 schema:sdDatePublished 2022-01-01T18:15
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N524b079d70ed46d59b896d440b3af76b
109 schema:url https://doi.org/10.1186/1476-4598-4-7
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N16ea8b02400646c9966e79c5a5e0c295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N1f22096a0e7c4062a400cbb042c1f0c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Neoplasm Invasiveness
118 rdf:type schema:DefinedTerm
119 N211e4ec402e54e6b89326a57ad46b26c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Ovarian Neoplasms
121 rdf:type schema:DefinedTerm
122 N25b0688b371f431194115aab06f7f332 rdf:first sg:person.01364414205.48
123 rdf:rest N3c28ec801cb84ac9a8f2a5e5de5b1419
124 N37e7cba1fe8347be96b23995f8e9946b rdf:first sg:person.01354314446.15
125 rdf:rest Nc62db7a5b793447f84625520790192f5
126 N3c28ec801cb84ac9a8f2a5e5de5b1419 rdf:first sg:person.01266571735.20
127 rdf:rest Nba330d7276ec4013bf8d298811178e77
128 N46d39e96b9ab4792bd7a580ac5681538 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name RNA, Small Interfering
130 rdf:type schema:DefinedTerm
131 N524b079d70ed46d59b896d440b3af76b schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N5acc90b72621475c97e2f112e096d5cc schema:name dimensions_id
134 schema:value pub.1029582210
135 rdf:type schema:PropertyValue
136 N649c0a772ee941e6bc0ea1beaed00516 schema:name pubmed_id
137 schema:value 15686601
138 rdf:type schema:PropertyValue
139 N67514d410ecf40aaa5a34f04d52bce49 rdf:first sg:person.010300733047.04
140 rdf:rest Nb364a3dc00204762bca88e6499239953
141 N6d72cd00110343fb8a3a33dbb5410c84 rdf:first sg:person.014144227613.61
142 rdf:rest N8e8a2ded55184d509eb39ce28253e909
143 N8a3c118b154643bd8c5d3602e545bb1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Insulin-Like Growth Factor Binding Protein 2
145 rdf:type schema:DefinedTerm
146 N8e8a2ded55184d509eb39ce28253e909 rdf:first sg:person.01243262074.71
147 rdf:rest N37e7cba1fe8347be96b23995f8e9946b
148 N99cdcb5d38004771b850352aff596872 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Cell Line, Tumor
150 rdf:type schema:DefinedTerm
151 N9b57ab8056ee4181820ac9e56800f9b6 schema:volumeNumber 4
152 rdf:type schema:PublicationVolume
153 Nb364a3dc00204762bca88e6499239953 rdf:first sg:person.01117750401.28
154 rdf:rest N25b0688b371f431194115aab06f7f332
155 Nb9b3998dd2ae41a4a19401a2cf6e4cae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Female
157 rdf:type schema:DefinedTerm
158 Nba330d7276ec4013bf8d298811178e77 rdf:first sg:person.016617025407.36
159 rdf:rest rdf:nil
160 Nc62db7a5b793447f84625520790192f5 rdf:first sg:person.013334470427.89
161 rdf:rest N67514d410ecf40aaa5a34f04d52bce49
162 Nf1255d1c23024f9e856ce717cdf899ac schema:issueNumber 1
163 rdf:type schema:PublicationIssue
164 Nf820e34dc72e40d3919f7c75138658e2 schema:name doi
165 schema:value 10.1186/1476-4598-4-7
166 rdf:type schema:PropertyValue
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
171 schema:name Clinical Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
174 schema:name Oncology and Carcinogenesis
175 rdf:type schema:DefinedTerm
176 sg:journal.1031030 schema:issn 1476-4598
177 schema:name Molecular Cancer
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.010300733047.04 schema:affiliation grid-institutes:grid.240145.6
181 schema:familyName Liu
182 schema:givenName Jinsong
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010300733047.04
184 rdf:type schema:Person
185 sg:person.01117750401.28 schema:affiliation grid-institutes:grid.502801.e
186 schema:familyName Niemistö
187 schema:givenName Antti
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117750401.28
189 rdf:type schema:Person
190 sg:person.01243262074.71 schema:affiliation grid-institutes:grid.502801.e
191 schema:familyName Mircean
192 schema:givenName Cristian
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243262074.71
194 rdf:type schema:Person
195 sg:person.01266571735.20 schema:affiliation grid-institutes:grid.414964.a
196 schema:familyName Lee
197 schema:givenName Je-Ho
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266571735.20
199 rdf:type schema:Person
200 sg:person.013334470427.89 schema:affiliation grid-institutes:grid.240145.6
201 schema:familyName Wang
202 schema:givenName Huamin
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334470427.89
204 rdf:type schema:Person
205 sg:person.01354314446.15 schema:affiliation grid-institutes:grid.240145.6
206 schema:familyName Shmulevich
207 schema:givenName Ilya
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354314446.15
209 rdf:type schema:Person
210 sg:person.01364414205.48 schema:affiliation grid-institutes:grid.240145.6
211 schema:familyName Kavanagh
212 schema:givenName John J
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364414205.48
214 rdf:type schema:Person
215 sg:person.014144227613.61 schema:affiliation grid-institutes:grid.414964.a
216 schema:familyName Lee
217 schema:givenName Eun-Ju
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014144227613.61
219 rdf:type schema:Person
220 sg:person.016617025407.36 schema:affiliation grid-institutes:grid.240145.6
221 schema:familyName Zhang
222 schema:givenName Wei
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016617025407.36
224 rdf:type schema:Person
225 sg:pub.10.1007/s00428-003-0786-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075266389
226 https://doi.org/10.1007/s00428-003-0786-2
227 rdf:type schema:CreativeWork
228 sg:pub.10.1016/j.jsgi.2003.07.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054739612
229 https://doi.org/10.1016/j.jsgi.2003.07.004
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/bjc.1990.163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035416773
232 https://doi.org/10.1038/bjc.1990.163
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/bjc.1996.206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004364659
235 https://doi.org/10.1038/bjc.1996.206
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/modpathol.3800120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038132444
238 https://doi.org/10.1038/modpathol.3800120
239 rdf:type schema:CreativeWork
240 grid-institutes:grid.240145.6 schema:alternateName Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
241 Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
242 schema:name Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
243 Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
244 rdf:type schema:Organization
245 grid-institutes:grid.414964.a schema:alternateName Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135–710, Korea
246 schema:name Department of Gynecologic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
247 Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
248 Molecular Therapy Research Center, Samsung Medical Center, Seoul, 135–710, Korea
249 rdf:type schema:Organization
250 grid-institutes:grid.502801.e schema:alternateName Institute of Signal Processing, Tampere University of Technology, Tampere, Finland
251 schema:name Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, 77030, USA
252 Institute of Signal Processing, Tampere University of Technology, Tampere, Finland
253 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...